News + Filings Holdings
|
Aristotle Capital Boston, LLC
> SUPN
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,161,947 | 6,798 | 34,928,115,000 | -6,922,956,000 | $30,059.99 |
03/31/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,155,149 | 28,268 | 41,851,071,000 | 1,655,226,000 | $36,230.02 |
12/31/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,126,881 | -30,672 | 40,195,845,000 | 40,156,662,000 | $35,670.00 |
09/30/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,157,553 | -110,187 | 39,183,000 | 2,520,000 | $33.85 |
06/30/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,267,740 | 9,673 | 36,663,000 | -3,998,000 | $28.92 |
03/31/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,258,067 | -27,805 | 40,661,000 | 3,165,000 | $32.32 |
12/31/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,285,872 | -32,237 | 37,496,000 | 2,342,000 | $29.16 |
09/30/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,318,109 | 256,456 | 35,154,000 | 2,466,000 | $26.67 |
06/30/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,061,653 | 40,027 | 32,688,000 | 6,984,000 | $30.79 |
12/31/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,021,626 | -50,826 | 25,704,000 | 3,354,000 | $25.16 |
09/30/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,072,452 | 44,614 | 22,350,000 | -2,061,000 | $20.84 |
06/30/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,027,838 | 287,199 | 24,411,000 | 11,087,000 | $23.75 |
03/31/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 740,639 | -16,864 | 13,324,000 | -4,644,000 | $17.99 |
12/31/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 757,503 | 13,511 | 17,968,000 | -2,477,000 | $23.72 |
09/30/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 743,992 | 675,050 | 20,445,000 | 18,164,000 | $27.48 |
06/30/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 104,031 | 104,031 | 3,442,000 | 3,442,000 | $33.09 |
<< Prev Next >> |
|